Positron Corporation
RELATED CONTENT
September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...
September 08, 2023 
July 25, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that ...
July 25, 2023 
Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the complete compounding process, from generator elution to dose distribution, of multiple diagnostic SPECT agents in an environment engineered to be ISO Class 5 and USP 797 compliant. Designed for facilities dispensing as many as 300 patient-specific doses per day, the PosiRx 3000-Series will benefit providers and patients by enabling unit dose radiopharmaceuticals to be prepared more cost effectively and accurately than previously possible.
May 16, 2013 August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical operations from the Crown Point, Ind. facility to its Lubbock, Texas site.
August 14, 2012 January 20, 2012 – Nuclear cardiology imaging company Positron Corp. this week acquired Manhattan Isotope Technology LLC (MIT). Positron has acquired all of the assets, business operations and retained all employees of MIT. In exchange, MIT shall receive cash advances, assumption of certain indebtedness and earn-out consideration of $3.5 million based on 20 percent of the net income from sales relating to radioisotope and radiopharmaceutical operations of MIT.
January 20, 2012 
June 14, 2011 – Positron, a molecular imaging company specializing in the field of nuclear cardiology, is relocating its corporate headquarters, research and development and product manufacturing facilities to Noblesville, Ind. Positron also plans to develop a high-energy 70 MeV cyclotron project and radiopharmaceutical manufacturing facility, also to be located in Noblesville.
June 14, 2011 
March 23, 2010 – Frost and Sullivan gave a 2010 North American New Product Innovation Award to Positron Corp. for its pioneering cardiac positron emission tomography (PET) scanner, the Attrius.
March 24, 2010 
September 30, 2009 – Positron Corp. predicts a significant rise in demand for cardiac PET in 2010 with a proposed cut in SPECT reimbursement of 46 percent and an increase in PET reimbursement of 22 percent, issued by the Centers for Medicare & Medicaid Services (CMS).
September 29, 2009 October 17, 2007 - Positron Corp. introduced its new dedicated-Cardiac PET system, Attrius, at the annual meeting of the ...
October 16, 2007 June 5, 2007 - Positron Corp. announced that it will launch in spring of 2008 a new dedicated-PET scanner for cardiac ...
June 04, 2007